evipedia.ai
← Back

Topical Urolithin A for Skin Rejuvenation

Created on 10/24/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Topical urolithin A, a purified gut-bacteria compound best known as an oral supplement, is sold in face creams and serums on the idea that helping skin cells renew their energy-producing structures slows visible aging. The case rests on a narrow base: a modest reduction in fine lines around the eyes after two months of twice-daily use, from company-run studies only. Short-term safety looks favorable; longer use is unstudied. (Full Review)

Protocol

Concentration
1% urolithin A
In a cream base; 0.5% showed no measurable effect on wrinkles or redness
Frequency and split dosing
Twice daily
Morning and evening, on face and forearms in the controlled trial
Duration
At least 8 weeks
Continuous use before judging effect, matching the trial duration
Time to effect
Wrinkle depth around the eyes
8 weeks
Trended lower at 2 weeks (not significant); differed significantly from placebo at 8 weeks
Skin hydration
8 weeks
Reported higher than on untreated skin only in a non-peer-reviewed trial where participants knew their product

Benefits

Contraindications
  • Pregnant or breastfeeding women
  • People with active skin disease, wounds or irritated skin at the application site
  • People with documented allergies to face or eye care products
  • People within 2 weeks of vitamin A or fruit-acid peel treatment, within 2 years of intense pulsed light, chemical peel, dermabrasion or botulinum toxin, or after any past laser treatment at the site (trial exclusion thresholds)
  • People with known allergy to urolithin A or any inactive ingredient in the product
    •
Key Interactions
  • Prescription topical retinoids (tretinoin, tazarotene): Caution (theoretical); layering actives may add redness and peeling
  • Anticoagulant and antiplatelet drugs (warfarin, apixaban, clopidogrel): Monitor (theoretical); added bleeding risk is unproven
  • Over-the-counter aspirin and NSAIDs (ibuprofen, naproxen): Monitor (theoretical); added bruising or bleeding is conceivable
  • Over-the-counter benzoyl peroxide and alpha-hydroxy acids (glycolic, lactic acid): Caution (theoretical); may add irritation
  • Oral urolithin A supplements (Mitopure softgels, generic urolithin A capsules): Monitor (theoretical); combined routes raise total exposure
  • Supplements with additive antiplatelet activity (fish oil, ginkgo, high-dose vitamin E): Monitor (theoretical); additive bruising is conceivable only if meaningful absorption occurs
  • Other topical antioxidants (vitamin C serum, niacinamide): No interaction expected (theoretical)
  • Aesthetic procedures (laser, chemical peels, microneedling, IPL): Caution (theoretical); may raise absorption and irritation
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Skin irritation or allergic contact reaction
    •
  • Speculative: Growth arrest of skin cells; disturbed skin barrier signaling; increased bleeding tendency
    •

Monitoring

Marker Target Why
Wrinkle depth around the eyes No established target; track percentage change from own baseline Efficacy marker
Skin hydration No established target; track change from own baseline Efficacy marker
Application-site reaction No established target; track any redness, itching, swelling or blistering Safety check: a reaction stops use

Cadence: Baseline photographs and 7-day forearm patch test; application sites checked daily for the first 2 weeks; photographs and any clinic measurements repeated at 2 weeks and 8 weeks, then every 3 months while use continues

Qualitative Assessment

  • Visibility of fine lines around the eyes in consistent lighting
  • Skin smoothness and texture to the touch
  • Stinging, burning or redness after application
  • Perceived dryness or tightness during the day
  • Overall tolerance of the full skincare routine
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.